Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology

Journal of Alzheimer's Disease

Volumn 55, Issue 2, 2017, Pages 749-762

  Rueli, Rachel H L H ^a   Torres, Daniel J ^a   Dewing, Andrea S T ^a   Kiyohara, Arlene C ^a   Barayuga, Stephanie M ^a   Bellinger, Miyoko T ^a   Uyehara Lock, Jane H ^a   White, Lon R ^b   Moreira, Paula I ^c,e   Berry, Marla J ^a   Perry, George ^d   Bellinger, Frederick P ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b PACIFIC HEALTH RESEARCH AND EDUCATION INSTITUTE   (United States)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; endoplasmic reticulum stress; neurofibrillary tangle; selenium; selenoprotein; tau

Indexed keywords

AMYLOID BETA PROTEIN; SELENATE; SELENOPROTEIN; SELENOPROTEIN S; SMALL INTERFERING RNA; TAU PROTEIN; UNCLASSIFIED DRUG; GLUCOSE; LEUCINE; MEMBRANE PROTEIN; MESSENGER RNA; PROLINE; VIMP PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; BRAIN NERVE CELL; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; AGED; ANALYSIS OF VARIANCE; BRAIN; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; NEUROBLASTOMA; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; LEUCINE; MEMBRANE PROTEINS; MUTATION; NEUROBLASTOMA; PHOSPHORYLATION; PROLINE; RNA, MESSENGER; RNA, SMALL INTERFERING; SELENOPROTEINS; TAU PROTEINS; TRANSFECTION;

EID: 84999116043     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-151208     Document Type: Article

References (57)

1. Corcoran NM, Martin D, Hutter-Paier B, Windisch M, Nguyen T, Nheu L, Sundstrom LE, Costello AJ, Hovens CM (2010) Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model. J Clin Neurosci 17, 1025-1033.
2. van Eersel J Ke YD, Liu X, Delerue F, Kril JJ, Gotz J, Ittner LM (2010) Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. Proc Natl Acad SciUSA107, 13888-13893.
3. Bosse AC, Pallauf J, Hommel B, Sturm M, Fischer S,Wolf NM, Mueller AS (2011) Impact of selenite and selenate on differentially expressed genes in rat liver examined by microarray analysis. Biosci Rep 30, 293-306.
4. Hill KE, Xia Y, Akesson B, Boeglin ME, Burk RF (1996) Selenoprotein P concentration in plasma is an index of selenium status in selenium-deficient and seleniumsupplemented Chinese subjects. J Nutr 126, 138-145.
5. Persson-Moschos M, Alfthan G, Akesson B (1998) Plasma selenoprotein P levels of healthy males in different selenium status after oral supplementation with different forms of selenium. Eur J Clin Nutr 52, 363-367.
6. Bellinger FP,HeQP, BellingerMT, LinY, RamanAV, White LR, Berry MJ (2008) Association of selenoprotein p with Alzheimer's pathology in human cortex. J Alzheimers Dis 15, 465-472.
7. Bulteau AL, Chavatte L (2015) Update on selenoprotein biosynthesis. Antioxid Redox Signal 23, 775-794.
8. Bellinger FP, RamanAV, Reeves MA, BerryMJ(2009) Regulation and function of selenoproteins in human disease. Biochem J 422, 11-22.
9. Pillai R, Uyehara-Lock JH, Bellinger FP (2014) Selenium and selenoprotein function in brain disorders. IUBMB Life 66, 229-239.
10. Fradejas N, Pastor MD, Mora-Lee S, Tranque P, Calvo S (2008) SEPS1 gene is activated during astrocyte ischemia and shows prominent antiapoptotic effects. J Mol Neurosci 35, 259-265.
11. Gao Y, Hannan NR, Wanyonyi S, Konstantopolous N, Pagnon J, Feng HC, Jowett JB, Kim KH,Walder K, Collier GR (2006) Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Cytokine 33, 246-251.
12. Curran JE, Jowett JB, Elliott KS, Gao Y, Gluschenko K, Wang J, Abel Azim DM, Cai G, Mahaney MC, Comuzzie AG, Dyer TD,Walder KR, Zimmet P, MacCluer JW, Collier GR, Kissebah AH, Blangero J (2005) Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 37, 1234-1241.
13. Ye Y, Shibata Y, Kikkert M, van Voorden S, Wiertz E, Rapoport TA (2005) Inaugural Article: Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proc Natl Acad Sci U S A 102, 14132-14138.
14. Roth S, Zhang S, Chiu J, Wirth EK, Schweizer U (2010) Development of a serum-free supplement for primary neuron culture reveals the interplay of selenium and vitamin E in neuronal survival. J Trace Elem Med Biol 24, 130-137.
15. Copanaki E, Schurmann T, Eckert A, Leuner K, Muller WE, Prehn JH, Kogel D (2007) The amyloid precursor protein potentiates CHOP induction and cell death in response to ER Ca2+ depletion. Biochim Biophys Acta 1773, 157-165.
16. Preston AM, Gurisik E, Bartley C, Laybutt DR, Biden TJ (2009) Reduced endoplasmic reticulum (ER)-to-Golgi protein trafficking contributes to ER stress in lipotoxic mouse beta cells by promoting protein overload. Diabetologia 52, 2369-2373.
17. Chan S-W, Egan PA (2005) Hepatitis C virus envelope proteins regulate CHOP via induction of the unfolded protein response. FASEB J 19, 1510-1512.
18. Nasreddine ZS, Loginov M, Clark LN, Lamarche J, Miller BL, Lamontagne A, Zhukareva V, Lee VM, Wilhelmsen KC, Geschwind DH (1999) From genotype to phenotype: A clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation. Ann Neurol 45, 704-715.
19. Rueli RH, Parubrub AC, Dewing AS, Hashimoto AC, Bellinger MT, Weeber EJ, Uyehara-Lock JH, White LR, Berry MJ, Bellinger FP (2015) Increased selenoprotein P in choroid plexus and cerebrospinal fluid in Alzheimer's disease brain. J Alzheimers Dis 44, 379-383.
20. Shchedrina VA, Zhang Y, Labunskyy VM, Hatfield DL, Gladyshev VN (2010) Structure-function relations, physiological roles, and evolution of mammalian ER-resident selenoproteins. Antioxid Redox Signal 12, 839-849.
21. Kim KH, Gao Y,Walder K, Collier GR, Skelton J, Kissebah AH (2007) SEPS1 protects RAW264.7 cells from phar-macological ER stress agent-induced apoptosis. Biochem Biophys Res Commun 354, 127-132.
22. Samali A, Fitzgerald U, Deegan S, Gupta S (2010) Methods for monitoring endoplasmic reticulum stress and the unfolded protein response. Int J Cell Biol 2010, 830307.
23. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, Clark SG, Ron D (2002) IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415, 92-96.
24. GaoY, Feng HC,Walder K, Bolton K, SunderlandT, Bishara N, Quick M, Kantham L, Collier GR (2004) Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress-SelS is a novel glucose-regulated protein. FEBS Lett 563, 185-190.
25. Kleman AM, Yuan JY, Aja S, Ronnett GV, Landree LE (2008) Physiological glucose is critical for optimized neuronal viability and AMPK responsiveness in vitro. J Neurosci Methods 167, 292-301.
26. Resende R, Ferreiro E, Pereira C, Oliveira CR (2008) ER stress is involved in Abeta-induced GSK-3beta activation and tau phosphorylation. J Neurosci Res 86, 2091-2099.
27. Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, ScheperW(2009) The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am J Pathol 174, 1241-1251.
28. Kudo T, Katayama T, Imaizumi K, Yasuda Y, Yatera M, Okochi M, Tohyama M, Takeda M (2002) The unfolded protein response is involved in the pathology of Alzheimer's disease. Ann N Y Acad Sci 977, 349-355.
29. YeY, ShibataY,YunC, Ron D, Rapoport TA(2004)Amembrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429, 841-847.
30. Fradejas N, Serrano-Perez Mdel C, Tranque P, Calvo S (2011) Selenoprotein S expression in reactive astrocytes following brain injury. Glia 59, 959-972.
31. Lindholm D, Wootz H, Korhonen L (2006) ER stress and neurodegenerative diseases. Cell Death Differ 13, 385-392.
32. Salminen A, Kauppinen A, Suuronen T, Kaarniranta K, Ojala J (2009) ER stress in Alzheimer's disease: A novel neuronal trigger for inflammation and Alzheimer's pathology. J Neuroinflammation 6, 41.
33. Hoozemans JJ, Veerhuis R, Van Haastert ES, Rozemuller JM, Baas F, Eikelenboom P, ScheperW(2005) The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol 110, 165-172.
34. Gotz J, David D, Hoerndli F, Ke YD, Schonrock N,Wiesner A, Fath T, Bokhari L, Lim YA, Deters N, Ittner LM (2008) Functional genomics dissects pathomechanisms in tauopathies: Mitosis failure and unfolded protein response. Neurodegener Dis 5, 179-181.
35. Abisambra JF, Jinwal UK, Blair LJ, O'Leary JC 3rd, Li Q, Brady S,Wang L, Guidi CE, Zhang B, Nordhues BA, Cockman M, Suntharalingham A, Li P, Jin Y, Atkins CA, Dickey CA (2013) Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation. J Neurosci 33, 9498-9507.
36. Lee YJ, Kim JE, Kwak MH, Go J, Yang SY, Kwon HS, Kim BC, Kim JM, Hwang DY (2014) Selenium treatment significantly inhibits tumor necrosis factor-alpha-induced cell death and tau hyperphosphorylation in neuroblastoma cells. Mol Med Rep 10, 1869-1874.
37. Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, Ahmad A, Shrivastav P, Islam F (2009) Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's disease. Brain Res 1281, 117-127.
38. Gwon AR, Park JS, Park JH, Baik SH, Jeong HY, Hyun DH, Park KW, Jo DG (2010) Selenium attenuates A beta production and A beta-induced neuronal death. Neurosci Lett 469, 391-395.
39. Song G, Zhang Z,Wen L, Chen C, Shi Q, Zhang Y, Ni J, Liu Q (2014) Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 41, 85-99.
40. Lovell MA, Xiong S, Lyubartseva G, Markesbery WR (2009) Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice. Free Radic Biol Med 46, 1527-1533.
41. Xiong S, Markesbery WR, Shao C, Lovell MA (2007) Seleno-L-methionine protects against beta-amyloid and iron/hydrogen peroxide-mediated neuron death. Antioxid Redox Signal 9, 457-467.
42. Xie L, Zheng W, Xin N, Xie JW, Wang T, Wang ZY (2012) Ebselen inhibits iron-induced tau phosphorylation by attenuatingDMT1up-regulation and cellular iron uptake. Neurochem Int 61, 334-340.
43. Pinton S, Bruning CA, Sartori Oliveira CE, Prigol M, Nogueira CW (2013) Therapeutic effect of organoselenium dietary supplementation in a sporadic dementia of Alzheimer's type model in rats. J Nutr Biochem 24, 311-317.
44. Pinton S, da Rocha JT, Gai BM, Prigol M, da Rosa LV, Nogueira CW (2011) Neuroprotector effect of p,p'-methoxyl-diphenyl diselenide in a model of sporadic dementia of Alzheimer's type in mice: Contribution of antioxidant mechanism. Cell Biochem Funct 29, 235-243.
45. Pinton S, da Rocha JT, Zeni G, Nogueira CW (2010) Organoselenium improves memory decline in mice: Involvement of acetylcholinesterase activity. Neurosci Lett 472, 56-60.
46. Pinton S, Souza AC, Sari MH, Ramalho RM, Rodrigues CM, Nogueira CW (2013) p,p'-Methoxyl-diphenyl diselenide protects against amyloid-beta induced cytotoxicity in vitro and improves memory deficits in vivo. Behav Brain Res 247, 241-247.
47. Wang Z,WangY, LiW, Mao F, SunY, Huang L, LiX(2014) Design, synthesis, and evaluation of multitarget-directed selenium-containing clioquinol derivatives for the treatment of Alzheimer's disease. ACS Chem Neurosci 5, 952-962.
48. HaratakeM,Yoshida S, Mandai M, FuchigamiT, Nakayama M (2013) Elevated amyloid-beta plaque deposition in dietary selenium-deficient Tg2576 transgenic mice. Metallomics 5, 479-483.
49. Hoefig CS, Renko K, Kohrle J, Birringer M, Schomburg L (2011) Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture. J Nutr Biochem 22, 945-955.
50. Chen P, Wang L, Wang Y, Li S, Shen L, Liu Q, Ni J (2014) Phosphoproteomic profiling of selenate-treated Alzheimer's disease model cells. PLoS One 9, e113307.
51. Shultz SR, Wright DK, Zheng P, Stuchbery R, Liu SJ, Sashindranath M, Medcalf RL, Johnston LA, Hovens CM, Jones NC, O'Brien TJ (2015) Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury. Brain 138, 1297-1313.
52. Jones NC, Nguyen T, Corcoran NM, Velakoulis D, Chen T, Grundy R, O'Brien TJ, Hovens CM (2012) Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models. Neurobiol Dis 45, 897-901.
53. Sontag JM, Sontag E (2014) Protein phosphatase 2A dysfunction in Alzheimer's disease. Front Mol Neurosci 7, 16.
54. Vinceti M, Grill P, Malagoli C, Filippini T, Storani S, Malavolti M, Michalke B (2015) Selenium speciation in human serum and its implications for epidemiologic research: A cross-sectional study. J Trace Elem Med Biol 31, 1-10.
55. Burk RF, Hill KE (2009) Selenoprotein P-expression, functions, and roles in mammals. Biochem Biophys Acta 1790, 1441-1447.
56. Cole AR, Astell A, Green C, Sutherland C (2007) Molecular connexions between dementia and diabetes. Neurosci Biobehav Rev 31, 1046-1063.
57. Li L, Holscher C (2007) Common pathological processes in Alzheimer disease and type 2 diabetes: A review. Brain Res Rev 56, 384-402.